# New Rhein: portfolio, investments and team > New Rhein is a private equity based in United States. 2 investments on record, 1 in the last 12 months, latest Feb 2026. Source: https://millionrounds.com/fund/new-rhein-healthcare-investors (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # New Rhein Last cheque observed Feb 2026; 2 cheques on record. Deploying now Private equity Seed Series A Series B Longevity Health-tech E-health Deploying now **100%** of best year **1** **cheques in 12 months**, 2 on record Since the last cheque **244** days **00** hrs **00** min **00** sec Median round **$104M** Cheque size, as they say **$100K – $50M** Rounds led **1 of 2** Sole investor **1 rounds** Pitch New Rhein ## New Rhein highlights - 01 1 cheques in the last 12 months - 02 Mostly Series A: 100% of its rounds - 03 Sole investor in 1 rounds, median $12M ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** $100K – $50M as they say - **Stages:** Seed Series A Series B Growth - **Sectors:** Longevity Health-tech E-health - **Based in:** Philadelphia, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **2 appearances** - **2026** 1 round - **Feb** **[Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc)** Series A · US · Seroba Life Sciences **$197M** *Led* - **2018** 1 round - **Dec** **[Neuraptive Therapeutics](https://millionrounds.com/company/neuraptive-therapeutics)** Series A · US · FinSMEs **$12M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **4 named** IP **Ivan Philip Gergel** Managing Partner & Chief Medical Officer i Form ADV NG **Nayan Greg Parekh** Founder & Managing Partner i Form ADV RW **Robert William Czesak** Chief Financial Officer i Form ADV SS **Subhanu Saxena** Managing Partner & Chief Compliance Officer i Form ADV We also hold **13** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$291M** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** NEW Rhein Healthcare Investors LLC - **SEC number:** CRD 300842 Funds on its Form ADV **5** private funds, **$145M** in gross assets · filed May 2024 - New Rhein Healthcare 18 L.P. *Venture* 21 investors $41M - New Rhein Healthcare 2021 (Lux) SCSP *Venture* 19 investors $34M - New Rhein Healthcare 18 (Parallel) SCSP *Venture* 8 investors $30M - New Rhein Healthcare 2021 Privak *Venture* 7 investors $20M - New Rhein Healthcare 2021 (DE) L.P. *Venture* 26 investors $19M ## What they claim to have backed From their own portfolio page (on their website) **0** of 1 we have independently watched raise Investor Portal Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## The cheque Seed Series A Series B Median round joined **$104M** the round, not its cheque Alone, median **$12M** Led 1 of 2 rounds **50%** - **Said size:** $100K – $50M - **Sole investor:** 1 rounds - **Last cheque:** Feb 2026 Rounds by stage said on their site - Series A said *2* - Seed said *-* - Series B said *-* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 **Pitching New Rhein?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies New Rhein put money into. [**Alveus Therapeutics Inc.** $197M · Feb 2026](https://millionrounds.com/company/alveus-therapeutics-inc)[**Neuraptive Therapeutics** $12M · Dec 2018](https://millionrounds.com/company/neuraptive-therapeutics) ## Quick answers about New Rhein ### What does New Rhein invest in? New Rhein invests most often at Series A (100% of the rounds on record), in sectors such as Longevity, Health-tech and E-health. ### How active is New Rhein? 2 investments on record, 1 of them in the last 12 months, and it led 1. The most recent was in Feb 2026. ### What has New Rhein invested in recently? Its most recent investments on record: Alveus Therapeutics Inc. (Series A, Feb 2026) and Neuraptive Therapeutics (Series A, Dec 2018). ### How big are New Rhein's cheques? The median round it joins is $104M. It says it writes cheques of $100K to $50M. ### Is New Rhein investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### What kind of investor is New Rhein? New Rhein is a private equity firm based in Philadelphia, United States. ### How much does New Rhein manage? About $291M, as regulatory assets under management (Oct 2026). ### When was New Rhein founded? New Rhein was founded in 2011. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=new-rhein-healthcare-investors) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=new-rhein-healthcare-investors)